Chlorphentermine
Clinical data | |
---|---|
Other names | p-Chloro-α,α-dimethylphenethylamine |
Routes of administration | Oral, Insufflated, Rectal |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Elimination half-life | 40 hours |
Excretion | Renal |
Identifiers | |
| |
JSmol) | |
| |
| |
(what is this?) (verify) |
Chlorphentermine (trade names Apsedon, Desopimon, Lucofen) is a serotonergic appetite suppressant of the amphetamine family. Developed in 1962, it is the 4-chloro derivative of the better known appetite suppressant phentermine,[2] which is still in current use.
Chlorphentermine acts as a highly selective
diethylpropion which have been more widely abused. It is no longer used due mainly to safety concerns, as it has a serotonergic effects profile similar to other withdrawn appetite suppressants such as fenfluramine and aminorex which were found to cause pulmonary hypertension and cardiac fibrosis following prolonged use.[4]
The plasma half-life is about five days.[5] It was withdrawn from the market in the UK in 1974.[5]
See also
- Aminorex
- Cericlamine
- Cloforex
- Clortermine
- Etolorex
- Fenfluramine
- Methylenedioxyphentermine
- Phentermine
References
- ^ Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
- PMID 13903304.
- S2CID 15573624.
- PMID 10458725.
- ^ S2CID 25704474.